'5 mg bid' presentation slideshows

Fibrinogen

Xa. Common Pathway. New Oral Agents. Xa Blocker. Apixaban Rivaroxaban. Dabigatran. Prothrombin. Thrombin. Clot. Fibrin. Fibrinogen. Replacing Traditional Anticoagulants. Treatment VTE UFH, LMWH Bridge to Warfarin. RE-COVER Study. Dabigatran 150 mg, BID for 6 months

718 views • 70 slides

Patricia P. Chang, MD MHS FACC Associate Professor, Medicine

Heart Failure in 2012. Patricia P. Chang, MD MHS FACC Associate Professor, Medicine Director, Heart Failure & Transplant Program February 25, 2012. Disclosures. No relationships to disclose I will discuss products that are investigational or used off-label. Case.

845 views • 67 slides

650 views • 47 slides

HEADACHES CHRONIC HEADACHE

HEADACHES CHRONIC HEADACHE. Determining Its quality,severity ,location,duration,and time course as well as the conditions that produce ,exacerbate or relieve it. Ausculation-Palpation Quality of cephalic pain in most patients is dull (not sharp localize) Throbbing D.D Waxing&Waning

609 views • 44 slides

Case presentation

439 views • 43 slides

401 views • 39 slides

Previous Clinical Experience

Previous Clinical Experience. Victor Sandor, MD VP Global Oncology Drug Development Incyte Corporation. The RESPONSE Trial CINC424B2301. Outline. INC424 clinical experience in healthy volunteers Key findings from: Single and multiple ascending dose studies Drug interaction studies

506 views • 33 slides

The Elephant in the Room: How to care for those with Emotional Dysregulation Disorders

The Elephant in the Room: How to care for those with Emotional Dysregulation Disorders. RMHC Discharge Liaison Team Carrie Howard, RN Pauline Barton, RN Hideko Saito-Dufton RN, CPMHN(c). Learning Objectives. To further define what constitutes Emotional Regulation disorders

314 views • 29 slides